• Can IBRX Stock Keep Its Pulse? Institutional Investors Buy In, Retail Hopes For Big Q2 Surprise TradingView Fri, 10 Jul 2026 07:53:55 GMT
• ibrx stock declines — immunitybio resubmits anktiva application to fda with additional data Stocktwits Thu, 09 Jul 2026 18:33:20 GMT
• Bronstein, Gewirtz & Grossman, LLC Encourages ImmunityBio, Inc The National Law Review Thu, 09 Jul 2026 16:06:54 GMT
• ibrx stock slips overnight: insider sale tests retail optimism ahead of fda growth catalyst Stocktwits Thu, 09 Jul 2026 12:28:24 GMT
• IBRX Stock In Spotlight As FDA Scrutiny Prompts ImmunityBio To Withdraw Content, Tighten Oversight Stocktwits Thu, 09 Jul 2026 03:06:03 GMT
• stock market today, feb. 18: immunitybio soars after eu approves anktiva for bladder cancer aol.com Thu, 09 Jul 2026 02:57:14 GMT
• IBRX Stock In Spotlight: ImmunityBio To Unveil Fresh Anktiva And BCG Data Next Week Stocktwits Thu, 09 Jul 2026 00:30:58 GMT
• ibrx stock rises premarket: anktiva moves into pre-surgery pancreatic cancer combo trial with bristol myers drug Stocktwits Wed, 08 Jul 2026 23:20:10 GMT
• ibrx stock slips overnight: insider sale tests retail optimism ahead of fda growth catalyst Stocktwits Wed, 08 Jul 2026 06:40:20 GMT
• immunitybio announces partnership to expand access to anktiva across 30 countries Stocktwits Wed, 08 Jul 2026 01:54:09 GMT
• immunitybio deadline today: rosen law firm encourages immunitybio, inc. investors with losses in excess of $100k to secure counsel... aol.com Tue, 07 Jul 2026 21:45:28 GMT
• ibrx stock rout deepens: founder points to cancer-fighting cell bank data as investors look for catalyst Stocktwits Tue, 07 Jul 2026 16:59:06 GMT
• immunitybio founder reaffirms grip as stock plunges in worst selloff since 2024 after massive rally Stocktwits Tue, 07 Jul 2026 15:51:54 GMT
• ibrx stock eyes best week since february: founder highlights new anktiva-nk cell therapy study Stocktwits Tue, 07 Jul 2026 12:58:21 GMT
• immunitybio’s q4 revenue gets a lift from anktiva sales – ibrx stock gains 11% Stocktwits Tue, 07 Jul 2026 09:39:48 GMT
• ImmunityBio Stock: A Long-Term Bull Case Worth Watching (NASDAQ:IBRX) Seeking Alpha Tue, 07 Jul 2026 08:07:39 GMT
• ImmunityBio Confirms Trial Strength For Anktiva In Bladder Cancer Stocktwits Tue, 07 Jul 2026 07:52:14 GMT
• immunitybio insider sold shares worth $1,439,066, according to a recent sec filing marketscreener.com Tue, 07 Jul 2026 07:49:19 GMT
• Form 4 Immunitybio Inc For: 6 July By Investing.com Investing.com Canada Tue, 07 Jul 2026 00:59:35 GMT
• ImmunityBio (IBRX) director sells 159,478 shares under 10b5-1 plan Stock Titan Tue, 07 Jul 2026 00:43:17 GMT
• ImmunityBio (IBRX) director trades 131K shares, exercises 55,979 options Stock Titan Tue, 07 Jul 2026 00:43:17 GMT
• ImmunityBio director Cheryl Cohen sells $1.25m in stock Investing.com Tue, 07 Jul 2026 00:40:55 GMT
• ibrx stock in spotlight: immunitybio to unveil fresh anktiva and bcg data next week Stocktwits Tue, 07 Jul 2026 00:28:35 GMT
• ibrx stock slips overnight: insider sale tests retail optimism ahead of fda growth catalyst TradingView Mon, 06 Jul 2026 05:57:00 GMT
• ibrx stock ignites retail frenzy ahead of founder’s prime-time tv blitz — traders bets on saudi funding and trump tailwinds Stocktwits Sun, 05 Jul 2026 21:51:44 GMT
• ibrx stock climbs overnight: immunitybio declares ‘all systems go’ for dunkirk anktiva manufacturing push Stocktwits Sun, 05 Jul 2026 20:44:09 GMT
• ibrx stock at 3-month high: retail bulls eye july catalysts around anktiva saudi expansion, q2 sales Stocktwits Sun, 05 Jul 2026 11:10:13 GMT
• ibrx stock still a buy after worst day in over a year? why this analyst is shrugging off fda warning letter Stocktwits Sat, 04 Jul 2026 17:42:01 GMT
• immunitybio's rally hits a technical barrier as short sellers circle and anktiva sales take center s Ad-hoc-news.de Sat, 04 Jul 2026 15:54:09 GMT
• ImmunityBio (IBRX) Is Up 8.4% After Russell Index Removal Amid Anktiva Expansion Efforts - What's Changed simplywall.st Sat, 04 Jul 2026 13:54:00 GMT
• ibrx stock in spotlight as fda scrutiny prompts immunitybio to withdraw content, tighten oversight Stocktwits Fri, 03 Jul 2026 16:20:47 GMT
• immunitybio founder pushes back after fda warning letter over anktiva claims — says ad 'never aired at all' Stocktwits Fri, 03 Jul 2026 15:42:53 GMT
• how high can ibrx stock go now? here’s what wall street thinks after saudi nod for bladder cancer filing Stocktwits Fri, 03 Jul 2026 14:32:55 GMT
• anktiva vs keytruda: immunitybio exec chair slams fda for double standards in approvals Stocktwits Fri, 03 Jul 2026 14:16:17 GMT
• ibrx stock enters heavy catalyst phase: traders brace for key anktiva decision amid trump’s fda turmoil Stocktwits Fri, 03 Jul 2026 11:45:51 GMT
• ibrx stock eyes best week since february: founder highlights new anktiva-nk cell therapy study Stocktwits Fri, 03 Jul 2026 11:12:56 GMT
• ImmunityBio (NASDAQ:IBRX) Screens as a High-Growth Momentum Stock Passing Minervini’s Trend Template ChartMill Fri, 03 Jul 2026 10:40:41 GMT
• ibrx stock at 3-month high: retail bulls eye july catalysts around anktiva saudi expansion, q2 sales Stocktwits Fri, 03 Jul 2026 09:51:18 GMT
• ibrx stock ignites retail frenzy ahead of founder’s prime-time tv blitz — traders bets on saudi funding and trump tailwinds Stocktwits Fri, 03 Jul 2026 08:48:40 GMT
• ibrx stock in spotlight: immunitybio to unveil fresh anktiva and bcg data next week Stocktwits Fri, 03 Jul 2026 04:39:53 GMT
• ibrx stock climbs overnight: immunitybio declares ‘all systems go’ for dunkirk anktiva manufacturing push Stocktwits Fri, 03 Jul 2026 01:03:10 GMT
• form 144 shows proposed sale of 55,979 shares by morgan stanley (ibrx) Stock Titan Thu, 02 Jul 2026 20:33:28 GMT
• ibrx stock rout deepens: founder points to cancer-fighting cell bank data as investors look for catalyst Stocktwits Thu, 02 Jul 2026 15:57:57 GMT
• ibrx stock in spotlight: immunitybio to unveil fresh anktiva and bcg data next week Stocktwits Thu, 02 Jul 2026 12:19:42 GMT
• immunitybio founder pushes back after fda warning letter over anktiva claims — says ad 'never aired at all' Stocktwits Thu, 02 Jul 2026 08:52:31 GMT
• ibrx stock at 3-month high: retail bulls eye july catalysts around anktiva saudi expansion, q2 sales Stocktwits Thu, 02 Jul 2026 06:21:11 GMT
• director christobel selecky sells 96,722 shares of immunitybio i GuruFocus Thu, 02 Jul 2026 00:31:50 GMT
• immunitybio confirms trial strength for anktiva in bladder cancer Stocktwits Wed, 01 Jul 2026 23:46:43 GMT
• form 144 immunitybio for: 1 july by investing.com Investing.com Canada Wed, 01 Jul 2026 22:42:08 GMT
• form 4 immunitybio inc for: 1 july by investing.com Investing.com Canada Wed, 01 Jul 2026 21:27:08 GMT
• ibrx stock down 10% this week, but its ceo just outlined 3 reasons bull case is intact Stocktwits Wed, 01 Jul 2026 21:15:17 GMT
• immunitybio insider sold shares worth $871,216, according to a recent sec filing Moomoo Wed, 01 Jul 2026 21:07:02 GMT
• ImmunityBio (IBRX) director pre-plans option exercises and sells 96,722 shares Stock Titan Wed, 01 Jul 2026 21:05:01 GMT
• immunitybio founder pushes back after fda warning letter over anktiva claims — says ad 'never aired at all' Stocktwits Wed, 01 Jul 2026 09:47:25 GMT
• immunitybio announces partnership to expand access to anktiva across 30 countries Stocktwits Tue, 30 Jun 2026 23:56:22 GMT
• ibrx stock in spotlight as fda scrutiny prompts immunitybio to withdraw content, tighten oversight Stocktwits Tue, 30 Jun 2026 22:29:08 GMT
• immunitybio founder pushes back after fda warning letter over anktiva claims — says ad 'never aired at all' Stocktwits Tue, 30 Jun 2026 21:04:17 GMT
• ibrx (nasdaq) insider exercise 1,000 shares; 95,722-share 10b5-1 sale Stock Titan Tue, 30 Jun 2026 20:36:18 GMT
• immunitybio highlights patient survey data at ispor 2026 showing The National Law Review Tue, 30 Jun 2026 18:58:37 GMT
• immunitybio confirms trial strength for anktiva in bladder cancer Stocktwits Tue, 30 Jun 2026 14:11:44 GMT
• ibrx stock is back: anktiva now targets severe pneumonia after clearing key checkpoint in bladder cancer trial Stocktwits Tue, 30 Jun 2026 04:15:23 GMT
• ibrx stock at 3-month high: retail bulls eye july catalysts around anktiva saudi expansion, q2 sales TradingView Tue, 30 Jun 2026 01:39:00 GMT
• immunitybio, inc.(nasdaqgs: ibrx) dropped from russell 2000 value benchmark marketscreener.com Mon, 29 Jun 2026 15:29:11 GMT
• ibrx stock declines — immunitybio resubmits anktiva application to fda with additional data Stocktwits Mon, 29 Jun 2026 13:20:13 GMT
• ImmunityBio (IBRX) Moves 11.8% Higher: Will This Strength Last? Yahoo Finance Mon, 29 Jun 2026 07:00:00 GMT
• enterprise value to revenue forward of immunitybio, inc. – nasdaq:ibrx TradingView Mon, 29 Jun 2026 05:47:01 GMT
• sls, ibrx eye green month as biotech etf gains steam: analyst sees ‘continued opportunities’ in immuno-oncology TradingView Mon, 29 Jun 2026 04:24:00 GMT
• immunitybio, inc.(nasdaqgs: ibrx) dropped from russell 2500 value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• immunitybio, inc.(nasdaqgs:ibrx) dropped from russell small cap comp value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• ibrx stock in spotlight: immunitybio to unveil fresh anktiva and bcg data next week Stocktwits Sun, 28 Jun 2026 20:30:49 GMT
• ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume TechStock² Sat, 27 Jun 2026 07:00:00 GMT
• form 4 immunitybio inc for: 26 june by investing.com Investing.com Nigeria Sat, 27 Jun 2026 04:04:26 GMT
• director barry simon sells 25,000 shares of immunitybio inc (ibr GuruFocus Sat, 27 Jun 2026 02:41:48 GMT
• immunitybio (nasdaq: ibrx) director sells 25,000 shares under 10b5-1 plan Stock Titan Sat, 27 Jun 2026 01:13:43 GMT
• immunitybio director simon barry j. sells $196,907 of common stock Investing.com Sat, 27 Jun 2026 01:05:39 GMT
• immunitybio (nasdaq:ibrx) rises as russell index rebalancing and high multiple draw buyers TechStock² Fri, 26 Jun 2026 19:25:55 GMT
• ibrx stock climbs overnight: immunitybio declares ‘all systems go’ for dunkirk anktiva manufacturing push Stocktwits Fri, 26 Jun 2026 11:45:19 GMT
• Is Speculation About a Russell 1000 Shift Quietly Rewriting ImmunityBio’s (IBRX) Investment Narrative? simplywall.st Fri, 26 Jun 2026 07:00:00 GMT
• ImmunityBio director Simon Barry J. sells $196,907 of common stock Investing.com Fri, 26 Jun 2026 07:00:00 GMT
• IBRX Stock Climbs As ANKTIVA Data Spotlight Draws Traders StocksToTrade Fri, 26 Jun 2026 07:00:00 GMT
• ibrx stock in spotlight as fda scrutiny prompts immunitybio to withdraw content, tighten oversight Stocktwits Thu, 25 Jun 2026 22:01:43 GMT
• immunitybio confirms trial strength for anktiva in bladder cancer Stocktwits Wed, 24 Jun 2026 16:17:12 GMT
• ImmunityBio (IBRX) Valuation In Focus After Russell 1000 Talk Lifts Interest simplywall.st Wed, 24 Jun 2026 07:00:00 GMT
• bronstein, gewirtz & grossman, llc is investigating immunitybio, inc. (immp) and encourages shareholders to connect ACCESS Newswire Sun, 21 Jun 2026 19:44:26 GMT
• immunitybio confirms trial strength for anktiva in bladder cancer Stocktwits Sun, 21 Jun 2026 11:29:33 GMT
• ibrx stock in spotlight as fda scrutiny prompts immunitybio to withdraw content, tighten oversight Stocktwits Sun, 21 Jun 2026 09:42:15 GMT
• ibrx stock climbs overnight: immunitybio declares ‘all systems go’ for dunkirk anktiva manufacturing push Stocktwits Sun, 21 Jun 2026 06:12:05 GMT
• immunitybio founder pushes back after fda warning letter over anktiva claims — says ad 'never aired at all' Stocktwits Fri, 19 Jun 2026 22:15:54 GMT
• Jim Cramer Says “Let ImmunityBio Be Your Speculation” to a Caller Yahoo Finance Fri, 19 Jun 2026 07:00:00 GMT
• ibrx stock in spotlight: immunitybio to unveil fresh anktiva and bcg data next week Stocktwits Fri, 19 Jun 2026 06:38:43 GMT
• immunitybio confirms trial strength for anktiva in bladder cancer Stocktwits Fri, 19 Jun 2026 06:19:58 GMT
• in pancreatic cancer, patrick soon-shiong makes promises he has not kept statnews.com Thu, 18 Jun 2026 14:59:56 GMT
• immunitybio founder pushes back after fda warning letter over anktiva claims — says ad 'never aired at all' Stocktwits Thu, 18 Jun 2026 02:37:32 GMT
• ibrx stock climbs overnight: immunitybio declares ‘all systems go’ for dunkirk anktiva manufacturing push Stocktwits Wed, 17 Jun 2026 20:44:28 GMT
• bronstein, gewirtz & grossman, llc announces an investigation against immunitybio, inc. (immp) and encourages investors to learn m... ACCESS Newswire Tue, 16 Jun 2026 19:29:50 GMT
• ibrx stock in spotlight as fda scrutiny prompts immunitybio to withdraw content, tighten oversight Stocktwits Tue, 16 Jun 2026 10:06:43 GMT
• immunitybio founder pushes back after fda warning letter over anktiva claims — says ad 'never aired at all' Stocktwits Tue, 16 Jun 2026 03:11:54 GMT
• immunitybio founder pushes back after fda warning letter over anktiva claims — says ad 'never aired at all' Stocktwits Mon, 15 Jun 2026 08:56:27 GMT
• immunitybio rises as anktiva label expansion undergoes fda review MSN Mon, 15 Jun 2026 08:42:22 GMT
• immunitybio, inc. (immp) investigation: bronstein, gewirtz & gros The National Law Review Sun, 14 Jun 2026 20:35:59 GMT
• ibrx stock climbs overnight: immunitybio declares ‘all systems go’ for dunkirk anktiva manufacturing push Stocktwits Sat, 13 Jun 2026 17:27:18 GMT
• how asco phase 3 anktiva data at immunitybio (ibrx) has changed its investment story simplywall.st Fri, 12 Jun 2026 07:00:00 GMT
• ibrx stock climbs overnight: immunitybio declares ‘all systems go’ for dunkirk anktiva manufacturing push Stocktwits Fri, 12 Jun 2026 00:38:01 GMT
• ibrx stock climbs overnight: immunitybio declares ‘all systems go’ for dunkirk anktiva manufacturing push Stocktwits Thu, 11 Jun 2026 17:08:16 GMT
• immunitybio confirms trial strength for anktiva in bladder cancer Stocktwits Thu, 11 Jun 2026 16:16:29 GMT
• immunitybio rises as anktiva label expansion undergoes fda review MSN Thu, 11 Jun 2026 12:49:22 GMT
• immunitybio (ibrx): one of the best performing growth stocks so far in 2026 Insider Monkey Thu, 11 Jun 2026 01:35:16 GMT
• immunitybio (ibrx) director awarded 65,600 stock options at $7.25 strike Stock Titan Thu, 11 Jun 2026 00:16:35 GMT
• immunitybio (ibrx) director wesley clark receives 65,600 stock options at $7.25 strike Stock Titan Thu, 11 Jun 2026 00:16:34 GMT
• immunitybio (ibrx) director christobel selecky awarded 65,600 stock options at $7.25 Stock Titan Thu, 11 Jun 2026 00:16:34 GMT
• immunitybio (ibrx) director granted 65,600 stock options at $7.25 strike Stock Titan Thu, 11 Jun 2026 00:16:32 GMT
• immunitybio (ibrx) director receives 65,600 stock options at $7.25 strike Stock Titan Thu, 11 Jun 2026 00:16:32 GMT
• director at immunitybio (nasdaq: ibrx) awarded 65,600 options Stock Titan Thu, 11 Jun 2026 00:16:30 GMT
• ImmunityBio (IBRX): One of the Best Performing Growth Stocks So Far in 2026 Yahoo Finance Wed, 10 Jun 2026 07:00:00 GMT
• immunitybio (ibrx) director granted 65,600 stock options at $7.25 strike Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• immunitybio (ibrx) re-elects full board, ratifies deloitte as 2026 auditor Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• immunitybio (ibrx) director receives 65,600 stock options at $7.25 strike Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• immunitybio (ibrx) director wesley clark receives 65,600 stock options at $7.25 strike Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• director at immunitybio (nasdaq: ibrx) awarded 65,600 options Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• a look at immunitybio (ibrx) valuation after fda review of anktiva and bcg combination simplywall.st Wed, 10 Jun 2026 07:00:00 GMT
• immunitybio (ibrx) director awarded 65,600 stock options at $7.25 strike Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• immunitybio (ibrx) director christobel selecky awarded 65,600 stock options at $7.25 Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• 2026-06-09 | bronstein, gewirtz & grossman, llc encourages immunitybio, inc. (immp) stockholders to inquire about securities inves... Stockhouse Tue, 09 Jun 2026 15:00:00 GMT
• ibrx stock climbs overnight: immunitybio declares ‘all systems go’ for dunkirk anktiva manufacturing push Stocktwits Mon, 08 Jun 2026 18:54:23 GMT
• immunitybio confirms trial strength for anktiva in bladder cancer Stocktwits Mon, 08 Jun 2026 12:50:04 GMT
• FDA to Review Expanded Use of Cancer Drug Los Angeles Business Journal Mon, 08 Jun 2026 07:00:00 GMT
• immunitybio founder pushes back after fda warning letter over anktiva claims — says ad 'never aired at all' Stocktwits Mon, 08 Jun 2026 06:58:43 GMT
• immunitybio, inc. (immp) investigation: bronstein, gewirtz & grossman, llc encourages stockholders to contact the firm to learn mo... ACCESS Newswire Sun, 07 Jun 2026 18:58:05 GMT
• immunitybio founder pushes back after fda warning letter over anktiva claims — says ad 'never aired at all' Stocktwits Sun, 07 Jun 2026 16:17:26 GMT
• immunitybio founder pushes back after fda warning letter over anktiva claims — says ad 'never aired at all' Stocktwits Sat, 06 Jun 2026 04:46:39 GMT
• immunitybio inc. (ibrx): one of the most shorted mid-cap stocks to buy now Insider Monkey Sat, 06 Jun 2026 01:51:25 GMT
• immunitybio earnings loom amid anktiva growth, fda scrutiny by investing.com Investing.com Nigeria Sat, 06 Jun 2026 01:43:21 GMT
• immunitybio confirms trial strength for anktiva in bladder cancer Stocktwits Sat, 06 Jun 2026 01:02:08 GMT
• ibrx stock climbs overnight: immunitybio declares ‘all systems go’ for dunkirk anktiva manufacturing push Stocktwits Fri, 05 Jun 2026 16:19:29 GMT
• ibrx stock declines — immunitybio resubmits anktiva application to fda with additional data Stocktwits Fri, 05 Jun 2026 11:10:23 GMT
• immunitybio founder pushes back after fda warning letter over anktiva claims — says ad 'never aired at all' Stocktwits Fri, 05 Jun 2026 10:40:05 GMT
• immunitybio (ibrx) is down 5.6% after new phase 3 anktiva lung cancer data release – has the bull case changed? simplywall.st Fri, 05 Jun 2026 09:29:51 GMT
• ImmunityBio Inc. (IBRX): One of the Most Shorted Mid-Cap Stocks to Buy Now Yahoo Finance Fri, 05 Jun 2026 07:00:00 GMT
• immunitybio (ibrx) director simon sells 23,033 shares under rule 10b5-1 plan Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• immunitybio director simon barry j. sells $165,305 in stock Investing.com Fri, 05 Jun 2026 07:00:00 GMT
• immunitybio earnings loom amid anktiva growth, fda scrutiny by investing.com Investing.com Nigeria Fri, 05 Jun 2026 07:00:00 GMT
• immunitybio responds to fda promotional compliance concerns Investing.com Fri, 05 Jun 2026 05:34:16 GMT
ImmunityBio, Inc(NASDAQ:IBRX) 
ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to combat multiple tumor types without the use of high-dose chemotherapy. It develops an albumin-linked chemotherapeutic therapy (Aldoxorubicin), a novel IL-15 cytokine superagonist (N-803), checkpoint inhibitors, m...
Share this website to your friends